LETROZOLE DEXCEL

Χώρα: Ισραήλ

Γλώσσα: Αγγλικά

Πηγή: Ministry of Health

Δραστική ουσία:

LETROZOLE

Διαθέσιμο από:

DEXCEL LTD, ISRAEL

Φαρμακολογική κατηγορία (ATC):

L02BG04

Φαρμακοτεχνική μορφή:

FILM COATED TABLETS

Σύνθεση:

LETROZOLE 2.5 MG

Οδός χορήγησης:

PER OS

Τρόπος διάθεσης:

Required

Κατασκευάζεται από:

HAUPT PHARMA MUNSTER GmbH, GERMANY

Θεραπευτική ομάδα:

LETROZOLE

Θεραπευτική περιοχή:

LETROZOLE

Θεραπευτικές ενδείξεις:

Letrozole - Dexcel tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole - Dexcel is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Ημερομηνία της άδειας:

2016-02-29